kvalia

kvalia is a private health‑care company headquartered in Sweden that specializes in the development, supply, and maintenance of medical devices, home‑care solutions, and data‑driven health monitoring services. Founded in the early 2000s, the company has grown through strategic acquisitions of smaller players in the automated care and remote patient monitoring sectors. kvalia’s product portfolio includes telemetry units for cardiovascular and respiratory monitoring, smart drug delivery systems, and a cloud‑based platform that aggregates sensor data for clinicians and care facilities.

The company operates across several European markets, primarily Germany, the United Kingdom, France, and Spain, while also maintaining a growing presence in the United States and Asia. kvalia partners with hospitals, long‑term care providers, and insurance companies to implement scalable remote monitoring programs that aim to reduce readmission rates and improve patient outcomes. In 2018, kvalia launched its “kvalia Health” suite, an integrated application that allows patients to view their vital signs, medication schedules, and receive alerts through a smartphone interface.

kvalia’s corporate structure incorporates a subsidiary that focuses on research and development, working in collaboration with academic institutions to advance sensor technology and predictive algorithms. The company emphasizes data security and regulatory compliance, adhering to the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the General Data Protection Regulation (GDPR) in Europe.

As of 2025, kvalia employs over 700 staff worldwide, reported annual revenues exceeding €140 million, and continues to expand its portfolio of connected health solutions in response to the increasing demand for personalized, remote patient care.